Corrigendum to "Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling".

[This corrects the article DOI: 10.1155/2020/5923572.].

In the article titled “Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling” [1], there are errors in the cleaved caspase-3 panel of Figure 4(a) and the DOX+Nrf2 siRNA panel of Figure 4(g).

Figure 1

Nrf2 knockdown reverses the protective effects of ORM1 in doxorubicin- (DOX-) treated H9c2 cells. (a, b) Western blot analysis of ORM1, Nrf2, HO-1, 4-HNE, and cleaved caspase-3. (c) Cell survival analysis using the Cell Counting Kit 8 (CCK-8). (d) Cellular malondialdehyde (MDA) content. (e, f) Fluorescence image (red fluorescence) of reactive oxygen species (ROS) measured using dichlorodihydrofluorescein diacetate (DCFH-DA). (g, h) Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining images with calculated apoptosis indices. Data are expressed as the mean ± standard error of the mean (SEM); n = 6. ∗∗P < 0.01 and ∗P < 0.05.

The authors mistakenly uploaded the incorrect Figure 4(g), while the error in Figure 4(a) was inadvertently introduced during the production process. The corrected Figure 4 is as follows.